Characterization of antigenic variants of hepatitis C virus in immune evasion

Virology Journal

Volumn 8, Issue , 2011, Pages

  Wang, Jane H ^a,b,c   Pianko, Matthew J ^b   Ke, Xiaogang ^a   Herskovic, Alex ^b   Hershow, Ronald ^c   Cotler, Scott J ^a   Chen, Weijin ^d   Chen, Zheng W ^c   Rong, Lijun ^c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Changchun Institute of Biological Products   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; GLYCOPROTEIN E1; INTERLEUKIN 10; PROTEIN VP1; PROTEIN VP2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; VIRUS ANTIGEN;

AMINO ACID SUBSTITUTION; ANTIGEN DETECTION; ANTIGENIC VARIATION; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH3 CELL; ADULT; CHEMISTRY; FEMALE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MONONUCLEAR CELL; PATHOGENICITY; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

HEPATITIS C VIRUS;

ADULT; AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; HEPACIVIRUS; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; T-LYMPHOCYTE SUBSETS;

EID: 79960871236     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-377     Document Type: Article

References (53)

1. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. Rehermann B, J Clin Invest 2009 119 1745 1754 10.1172/JCI39133 19587449
2. Adaptive immune responses in acute and chronic hepatitis C virus infection. Bowen DG, Walker CM, Nature 2005 436 946 952 10.1038/nature04079 16107834 (Pubitemid 41191670)
3. Immunology of hepatitis B virus and hepatitis C virus infection. Rehermann B, Nascimbeni M, Nat Rev Immunol 2005 5 215 229 10.1038/nri1573 15738952 (Pubitemid 40364823)
4. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, et al. Nat Med 2000 6 578 582 10.1038/75063 10802716 (Pubitemid 30305910)
5. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, et al. Hepatology 2001 33 267 276 10.1053/jhep.2001.21162 11124845 (Pubitemid 32016910)
6. Determinants of viral clearance and persistence during acute hepatitis C virus infection. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, et al. J Exp Med 2001 194 1395 1406 10.1084/jem.194.10.1395 11714747 (Pubitemid 33081515)
7. Cell mediated immune response to the hepatitis C virus. Rehermann B, Chisari FV, Curr Top Microbiol Immunol 2000 242 299 325 10592666 (Pubitemid 29467531)
8. Analysis of a successful immune response against hepatitis C virus. Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, et al. Immunity 1999 10 439 449 10.1016/S1074-7613(00)80044-8 10229187 (Pubitemid 29205480)
9. Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. Exley MA, He Q, Cheng O, Wang RJ, Cheney CP, et al. J Immunol 2002 168 1519 1523 11823474 (Pubitemid 34135741)
10. Immune responses and immunity in hepatitis C virus infection. Mizukoshi E, Rehermann B, J Gastroenterol 2001 36 799 808 10.1007/s005350170001 11777207 (Pubitemid 34036902)
11. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, et al. J Virol 2007 81 5882 5892 10.1128/JVI.02202-06 17376924 (Pubitemid 46847025)
12. NK cells: natural born killers in the conflict between humans and HCV. Koziel MJ, Hepatology 2006 43 395 397 10.1002/hep.21127 16496351
13. Cellular immune responses against hepatitis C virus. Koziel MJ, Clin Infect Dis 2005 41 Suppl 1 25 31 16265610
14. Flying under the radar: the immunobiology of hepatitis C. Dustin LB, Rice CM, Annu Rev Immunol 2007 25 71 99 10.1146/annurev.immunol.25.022106.141602 17067278 (Pubitemid 46697903)
15. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. Nature 2009 461 798 801 10.1038/nature08463 19759533
16. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. Nat Genet 2009 41 1100 1104 10.1038/ng.447 19749758
17. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Erickson AL, Kimura Y, Igarashi S, Eichelberger J, Houghton M, et al. Immunity 2001 15 883 895 10.1016/S1074-7613(01)00245-X 11754811 (Pubitemid 34075370)
18. HIV evolution: CTL escape mutation and reversion after transmission. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, et al. Nat Med 2004 10 282 289 10.1038/nm992 14770175 (Pubitemid 38667619)
19. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, et al. Science 2000 288 339 344 10.1126/science.288.5464.339 10764648 (Pubitemid 30226196)
20. Mutation rates among RNA viruses. Drake JW, Holland JJ, Proc Natl Acad Sci USA 1999 96 13910 13913 10.1073/pnas.96.24.13910 10570172
21. Viral hepatitis. Alter H, Hepatology 2006 43 230 234 10.1002/hep.21030 16447286
22. Hepatitis C virus mutation affects proteasomal epitope processing. Seifert U, Liermann H, Racanelli V, Halenius A, Wiese M, et al. J Clin Invest 2004 114 250 259 15254592 (Pubitemid 39071630)
23. Alteration at a single amino acid residue in the T cell receptor alpha chain complementarity determining region 2 changes the differentiation of naive CD4 T cells in response to antigen from T helper cell type 1 (Th1) to Th2. Blander JM, Sant'Angelo DB, Bottomly K, Janeway CA Jr, J Exp Med 2000 191 2065 2074 10.1084/jem.191.12.2065 10859331 (Pubitemid 30416353)
24. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells. Frasca L, Del Porto P, Tuosto L, Marinari B, Scotta C, et al. J Immunol 1999 163 650 658 10395654 (Pubitemid 29328069)
25. Immunity to viruses. Nash T, Immunology Edinberg, London, New York, Philadelphia, St Louis, Sydney, Toronto: Mosby, Roitt I, Brostoff J, Male D, sixth 2001 235 240
26. HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response. Feeney ME, Tang Y, Pfafferott K, Roosevelt KA, Draenert R, et al. J Immunol 2005 174 7524 7530 15944251 (Pubitemid 40806255)
27. CD8 epitope escape and reversion in acute HCV infection. Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, et al. J Exp Med 2004 200 1593 1604 10.1084/jem.20041006 15611288 (Pubitemid 40094183)
28. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. Dazert E, Neumann-Haefelin C, Bressanelli S, Fitzmaurice K, Kort J, et al. J Clin Invest 2009 119 376 386 19139562
29. HCV persistence and immune evasion in the absence of memory T cell help. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, et al. Science 2003 302 659 662 10.1126/science.1088774 14576438 (Pubitemid 37310924)
30. Immune responses during acute and chronic infection with hepatitis C virus. Ishii S, Koziel MJ, Clin Immunol 2008 128 133 147 10.1016/j.clim.2008.03. 525 18514579
31. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, et al. Hepatology 2002 35 190 198 10.1053/jhep.2002. 30293 11786976 (Pubitemid 34032560)
32. Control freaks: immune regulatory cells. Nagler-Anderson C, Bhan AK, Podolsky DK, Terhorst C, Nat Immunol 2004 5 119 122 10.1038/ni0204-119 14749778 (Pubitemid 38208349)
33. Immunology. Regulatory T cells get their chance to shine. Leslie M, Science 2011 332 1020 1021 10.1126/science.332.6033.1020 21617049
34. Natural regulatory T cells in infectious disease. Belkaid Y, Rouse BT, Nat Immunol 2005 6 353 360 15785761 (Pubitemid 41716772)
35. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, et al. Hepatology 2003 37 1189 1198 10.1053/jhep.2003.50194 12717401 (Pubitemid 36538697)
36. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. Ebinuma H, Nakamoto N, Li Y, Price DA, Gostick E, et al. J Virol 2008 82 5043 5053 10.1128/JVI.01548-07 18337568 (Pubitemid 351657064)
37. Hepatitis C virus induces regulatory T cells by naturally occurring viral variants to suppress T cell responses. Cusick MF, Schiller JJ, Gill JC, Eckels DD, Clin Dev Immunol 2011 2011 806061 21197453
38. Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection. Eckels DD, Wang H, Bian TH, Tabatabai N, Gill JC, Immunol Rev 2000 174 90 97 10.1034/j.1600-0528.2002.017403.x 10807509 (Pubitemid 30201381)
39. Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response. Wang JH, Layden TJ, Eckels DD, Hum Immunol 2003 64 662 673 10.1016/S0198-8859(03)00070-3 12826368 (Pubitemid 36828497)
40. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. Wang H, Eckels DD, J Immunol 1999 162 4177 4183 10201944 (Pubitemid 29314804)
41. Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus. Eckels DD, Zhou H, Bian TH, Wang H, Int Immunol 1999 11 577 583 10.1093/intimm/11.4.577 10323211 (Pubitemid 29179006)
42. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, et al. J Immunol 2004 172 5149 5153 15100250 (Pubitemid 38542009)
43. Control of regulatory T cell development by the transcription factor Foxp3. Hori S, Nomura T, Sakaguchi S, Science 2003 299 1057 1061 10.1126/science.1079490 12522256 (Pubitemid 36222930)
44. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. Carrier Y, Yuan J, Kuchroo VK, Weiner HL, J Immunol 2007 178 179 185 17182553 (Pubitemid 46033599)
45. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. Read S, Malmstrom V, Powrie F, J Exp Med 2000 192 295 302 10.1084/jem.192.2.295 10899916 (Pubitemid 30470312)
46. Hepatitis C virus infection: when silence is deception. Racanelli V, Rehermann B, Trends Immunol 2003 24 456 464 10.1016/S1471-4906(03)00178-9 12909460 (Pubitemid 36928104)
47. Sequence variation in the gene encoding the nonstructural 3 protein of hepatitis C virus: evidence for immune selection. Wang H, Bian T, Merrill SJ, Eckels DD, J Mol Evol 2002 54 465 473 10.1007/s00239-001-0037-6 11956685 (Pubitemid 34271127)
48. The immunological synapse: a molecular machine controlling T cell activation. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, et al. Science 1999 285 221 227 10.1126/science.285.5425.221 10398592 (Pubitemid 29329988)
49. Regulation of T-cell functions by MHC class II self-presentation. LeGuern C, Trends Immunol 2003 24 633 638 10.1016/j.it.2003.10.010 14644136 (Pubitemid 37485912)
50. TNF/TNFR family members in costimulation of T cell responses. Watts TH, Annu Rev Immunol 2005 23 23 68 10.1146/annurev.immunol.23.021704.115839 15771565 (Pubitemid 40563164)
51. Interface-disrupting amino acids establish specificity between T cell receptors and complexes of major histocompatibility complex and peptide. Huseby ES, Crawford F, White J, Marrack P, Kappler JW, Nat Immunol 2006 7 1191 1199 10.1038/ni1401 17041605 (Pubitemid 44594315)
52. The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets. Horwitz DA, Zheng SG, Gray JD, J Leukoc Biol 2003 74 471 478 10.1189/jlb.0503228 14519757 (Pubitemid 38040373)
53. Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection. Fuller MJ, Shoukry NH, Gushima T, Bowen DG, Callendret B, et al. Hepatology 2010 51 378 387 19918975